Acquiring Company
US WorldMeds Ventures
Acquired Company
Orbus Therapeutics
LouisvilleCaliforniaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiotechnologyDescription
US WorldMeds Ventures has acquired Orbus Therapeutics, expanding its commitment to rare diseases with the addition of Orbus' eflornithine program for gliomas. The merger enhances US WorldMeds' portfolio in treating recurrent Grade 3 astrocytoma. Orbus is now a wholly owned subsidiary.
Who to call at US WorldMeds Ventures, and when
When US WorldMeds Ventures changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day US WorldMeds Ventures raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at US WorldMeds Ventures, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at US WorldMeds Ventures. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment US WorldMeds Ventures makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Orbus Therapeutics?
Orbus Therapeutics was acquired by US WorldMeds Ventures, based in Louisville. The deal was reported on October 27, 2026. US WorldMeds Ventures, LLC is a pharmaceutical company focused on developing innovative treatments for rare diseases and underserved patient populations. US WorldMeds Ventures is privately held and operates in Biotechnology.
When did US WorldMeds Ventures acquire Orbus Therapeutics?
US WorldMeds Ventures's acquisition of Orbus Therapeutics was reported on October 27, 2026. US WorldMeds Ventures has acquired Orbus Therapeutics, expanding its commitment to rare diseases with the addition of Orbus' eflornithine program for gliomas. The merger enhances US WorldMeds' portfolio in treating recurrent Grade 3 astrocytoma. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Orbus Therapeutics do?
Orbus Therapeutics, Inc. is a privately held pharmaceutical company dedicated to developing investigational therapies for rare and serious brain tumors. The company is known for its innovative approach in treatments targeting difficult malignancies. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.